- List
- By Topic
- On Map
- Search Details

22901886 [PUBMED-IDS]
Need help? See RSS Feeds
Choose a feed type:

22901886 [PUBMED-IDS] (4 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT01000506 | Completed Has Results |
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
621 | All | 12 Years to 65 Years (Child, Adult) | NCT01000506 | 112997 | DREAM | November 1, 2009 | March 23, 2012 | March 23, 2012 | October 23, 2009 | January 24, 2018 | February 5, 2016 |
|
2 | NCT03324230 | Recruiting | Exploring Asthma Exacerbations in Mepolizumab Treated Patients |
|
Observational |
|
Other |
|
|
150 | All | 18 Years to 80 Years (Adult, Senior) | NCT03324230 | B17/30 | December 1, 2017 | June 2020 | June 2020 | October 27, 2017 | April 13, 2018 |
|
||||
3 | NCT03137199 | Recruiting | Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild Asthma |
|
|
Interventional | Phase 1 |
|
Other |
|
|
6 | All | 18 Years to 65 Years (Adult) | NCT03137199 | 20160350 | ASTEC | June 22, 2017 | June 2019 | December 2019 | May 2, 2017 | December 21, 2017 |
|
|
4 | NCT02559791 | Completed | Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma |
|
|
Interventional | Phase 2 Phase 3 |
|
Other / Industry |
|
|
10 | All | 18 Years to 75 Years (Adult, Senior) | NCT02559791 | RES-38072 | October 2015 | April 2017 | August 2017 | September 24, 2015 | April 4, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.